Portfolio company
Avistone
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops oncology drugs and precision therapies for patients with significant unmet medical needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Avistone Pharmaceuticals
The company develops and manufactures precision oncology medicines, specifically small-molecule targeted therapies for patients with lung cancer and other solid tumours.
Acrivon Therapeutics
This biopharmaceutical company develops precision oncology medicines and proteomics-based companion diagnostics for cancer patients.
Avenzo Therapeutics
This biotechnology company develops oncology therapies targeting solid tumours and metastatic breast cancer for patients with high unmet medical needs.
Auristone
This company develops epigenomic profiling tools and bioinformatics services for clinicians and researchers to support precision medicine and cancer drug discovery.
Synnovation Therapeutics
This company develops small molecule precision medicines and targeted therapies to treat cancer patients.
Scorpion
This company develops small molecule precision oncology therapies for patients with various cancers.
Black Diamond Therapeutics
This clinical-stage company develops precision oncology medicines and small molecule therapies for patients with genetically defined cancers.
Nuvectis Pharma
This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.
